Smith Group Asset Management’s Surmodics SRDX Stock Holding History

Smith Group Asset Management’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-51,990	Closed	-$1.14M	–	509
2015 Q3	$1.14M	Sell	51,990 -10	-0%	-$235	0.04%	160
2015 Q2	$1.22M	Buy	52,000 +800	+2%	+$20.1K	0.04%	165
2015 Q1	$1.33M	Sell	51,200 -3,900	-7%	-$92.9K	0.04%	161
2014 Q4	$1.22M	Buy	+55,100	New	+$1.17M	0.04%	172

Other funds holding SRDX

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Smith Group Asset Management's SRDX Position: Q4 2015 in Review

Smith Group Asset Management sold out of Surmodics (SRDX) in Q4 2015, closing a stake of 51,990 shares — an estimated $1.14M sold.

Smith Group Asset Management first reported a position in SRDX in Q4 2014 and held it in 4 quarters. The position peaked at $1.33M in Q1 2015. 120 funds tracked by Wall St. Rank hold SRDX as of Q4 2015.

Smith Group Asset Management reported no remaining Surmodics position as of Q4 2015 after selling out during the quarter.
Smith Group Asset Management sold 51,990 Surmodics shares in Q4 2015, an estimated $1.14M.
Smith Group Asset Management first reported a position in Surmodics in Q4 2014 and held it in 4 quarters.
Smith Group Asset Management's Surmodics position peaked at $1.33M in Q1 2015.
120 funds tracked by Wall St. Rank held Surmodics as of Q4 2015.

Based on Smith Group Asset Management's 13F filing for Q4 2015, filed 3 Feb 2016.